A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease

Trial Profile

A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin
  • Indications Thrombotic microangiopathy
  • Focus Therapeutic Use
  • Acronyms Challenge
  • Most Recent Events

    • 23 Sep 2016 Planned End Date changed from 1 Feb 2016 to 1 Oct 2018.
    • 23 Sep 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Aug 2018.
    • 23 Sep 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top